v3.19.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating Expenses:        
Research and development expenses $ 864,280 $ 188,435 $ 2,761,630 $ 320,838
General and administrative expenses 881,462 3,627,664 3,392,388 5,576,241
Total Operating Expenses 1,745,742 3,816,099 6,154,018 5,897,079
Loss From Operations (1,745,742) (3,816,099) (6,154,018) (5,897,079)
Other Income (Expense)        
Interest income 29,859 62,840
Loss on debt extinguishments (3,496,743) (3,484,502)
Warrant modification expense (441,763)
Interest expense and financing charges (878,082) (980,649)
Total other income (expense) 29,859 (4,374,825) (378,923) (4,465,151)
Loss Before Provision For Income Taxes (1,715,883) (8,190,924) (6,532,941) (10,362,230)
Provision for income taxes
Net Loss $ (1,715,883) $ (8,190,924) $ (6,532,941) $ (10,362,230)
Net loss per share, basic and diluted $ (0.17) $ (1.48) $ (0.68) $ (2.51)
Weighted average shares, basic and diluted 10,252,458 5,546,749 9,599,211 4,132,299

Source